Zura Bio Limited (ZURA) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 1 Strong Buy, 5 Buy, 1 Hold.
The consensus price target is $15.00, representing an upside of 162.2% from the current price $5.72.
Analysts estimate Earnings Per Share (EPS) of $-0.67 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.60 vs est $-0.67 (beat +9.9%). 2025: actual $-1.06 vs est $-0.80 (missed -33.3%). Analyst accuracy: 82%.
ZURA Stock — 12-Month Price Forecast
$15.00
▲ +162.24% Upside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Zura Bio Limited, the price target is $15.00.
The average price target represents a +162.24% change from the last price of $5.72.
ZURA Analyst Ratings
Buy
Based on 7 analysts giving stock ratings to Zura Bio Limited in the past 3 months
EPS Estimates — ZURA
82%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.60
vs Est –$0.67
▲ 11.0% off
2025
Actual –$1.06
vs Est –$0.80
▼ 25.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — ZURA
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
